MM cells have been shown to follow a similar pattern [254], and thus administration of anti-IL-6 antibody may be a solution for PI-resistance in MM or MCL and to down-regulate NF-κB in these cells. The gene discussed is NFKB1; the disease is Miyoshi myopathy.